+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KABRADG KABRADG

Kabra Drugs Share Price

₹20.20 +0.86 (4.45%)
43.13% Fall from 52W High

04 Sep, 2026 4:01 PM (IST)

Kabra Drugs live price: ₹20.20. It opened at ₹20 vs previous close ₹19; intraday high/low: ₹20/₹20. The 50 & 200 DMA stand at ₹22.50/₹23.40.

Kabra Drugs Performance

  • Today's Low
  • ₹20
  • Today's High
  • ₹20
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹36
  • Open Price₹20
  • Previous Close₹19
  • Volume54,141
  • 50 DMA₹22.50
  • 100 DMA₹23.50
  • 200 DMA₹23.40

Kabra Drugs Chart

Investment Returns

  • Over 1 Month -15.97%
  • Over 3 Month -12.89%
  • Over 6 Month -33.22%
  • Over 1 Year + 9.37%

Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!

Invest Now

Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 6.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 48
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1.6
  • EPS
  • 3.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -1
  • RSI
  • 36.43
  • MFI
  • 22.78

Latest Stock News Updates

Kabra Drugs Ltd - 524322 - Appointment Of Internal Auditor Of The Company

Appointment of Internal Auditor of the Company

Kabra Drugs Ltd - 524322 - Appointment Of Secretarial Auditor Of The Company

Appointment of Secretarial Auditor of the Company

Kabra Drugs Ltd - 524322 - Board Meeting Outcome for Outcome Of Board Meeting Held On 02Nd September 2026

Outcome of Board Meeting held on 02nd September 2026

Kabra Drugs Financials

Kabra Drugs Technicals

EMA & SMA

Current Price
₹20.20
+ 0.86 (4.45%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹21.30
  • 50 Day
  • ₹22.50
  • 100 Day
  • ₹23.50
  • 200 Day
  • ₹23.40

Resistance and Support

20 Pivot Speed
  • R3 20.90
  • R2 20.60
  • R1 20.30
  • S1 19.60
  • S2 19.30
  • S3 19.00

Kabra Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-02 Others
2026-08-12 Quarterly Results
2026-05-29 Quarterly Results
2026-05-06 Others Inter-alia, to consider 1. Pharmaceutical manufacturing & marketing expansion of own brands. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing. 3. Other business matters.
2026-04-21 Others Inter-alia, to consider 1. Appointment of Ms. Monam Kapoor as Additional Director. 2. Board will discuss the amendment of the Main Objects clause of the MOA. 3. Notice of POM. 4.Other business matters

Kabra Drugs Shareholding Pattern

100%
0%
0%

Kabra Drugs FAQs

Kabra Drugs share price is ₹20 As on 05 September, 2026 | 03:38

The Market Cap of Kabra Drugs is ₹47.9 Cr As on 05 September, 2026 | 03:38

The P/E ratio of Kabra Drugs is 6.3 As on 05 September, 2026 | 03:38

The PB ratio of Kabra Drugs is 1.5 As on 05 September, 2026 | 03:38

The 52 week High & Low of Kabra Drugs is ₹35.5/₹15.5 respectively As on 05 September, 2026 | 03:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23